CliffBio
small molecule

RUKOBIA

FOSTEMSAVIR TROMETHAMINE

Loss of exclusivityJuly 2029latest FDA-listed patent expiry
CompanyViiV Healthcare →See this company's full patent-cliff portfolio

Drug detail

Brand nameRUKOBIA
Active ingredientFOSTEMSAVIR TROMETHAMINE
StrengthEQ 600MG BASE
Dosage formTABLET, EXTENDED RELEASE
RouteORAL
ModalitySmall molecule
FDA approvalJuly 2020
Marketing statusRX

Listed patents

PatentExpiresType
8168615July 2029product
7745625November 2027substance

More from ViiV Healthcare

Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the latest FDA-listed patent expiry; estimates are projections, not legal advice.

RUKOBIA patent cliff — loss of exclusivity July 2029 | CliffBio